ApprovalTrail

Company · Toronto, Ontario, Canada

Leo Pharma Inc

Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.

Drug products (DIN)
50
30 authorized now
Natural health products
0
0 active licences
Medical device licences
0
0 active
Notices of Compliance
55

Drug products

Authorized products first.

NameDINStatus
ADTRALZA02521288Marketed
ADTRALZA02540193Marketed
ANZUPGO02560704Marketed
DOVOBET GEL02319012Marketed
DOVOBET OINTMENT02244126Marketed
DOVONEX01976133Marketed
ENSTILAR02457393Marketed
FINACEA02270811Marketed
FUCIBET02474883Marketed
FUCIDIN CREAM 2%00586668Marketed
FUCIDIN H02238578Marketed
FUCIDIN OINTMENT 2%00586676Marketed
HEPARIN LEO 100UNIT/ML00727520Marketed
HEPARIN LEO INJ 1000UNIT/ML00453811Marketed
INNOHEP02167840Marketed
INNOHEP02229515Marketed
INNOHEP02229755Marketed
INNOHEP02231478Marketed
INNOHEP02358158Marketed
INNOHEP02358166Marketed
INNOHEP02358174Marketed
INNOHEP02358182Marketed
INNOHEP02429462Marketed
INNOHEP02429470Marketed
INNOHEP02429489Marketed
PROTOPIC02244148Marketed
PROTOPIC02244149Marketed
SPEVIGO02536455Marketed
SPEVIGO02550296Marketed
SPEVIGO02561697Approved
BURINEX - TAB 2MG02176076Cancelled Post Market
CANAURAL (EAR DROPS)00727709Cancelled Post Market
DOVONEX - CRM 50MCG/GM02150956Cancelled Post Market
DOVONEX SOLUTION - TOP 50MCG/ML02194341Cancelled Post Market
FUCIDERM GEL02244695Cancelled Post Market
FUCIDIN FILM COATED TAB 250MG01934252Cancelled Post Market
FUCIDIN INTERTULLE 2%00586684Cancelled Post Market
FUCIDIN LEO INJECTION KIT02049406Cancelled Post Market
FUCIDIN LEO SUS 246MG/5ML00506036Cancelled Post Market
FUCITHALMIC VET (VISCOUS EYE DROPS)02231118Cancelled Post Market
HEPARIN LEO INJ 10000UNIT/ML00579718Cancelled Post Market
HEPARIN LEO INJ 25000UNIT/ML00453781Cancelled Post Market
INNOHEP DISP.SYR.-11700 ANTI-XA IU/ML02167859Cancelled Post Market
ONE-ALPHA02239431Cancelled Pre Market
ONE-ALPHA SOL 0.2MCG/ML00759546Cancelled Post Market
PICATO02400987Cancelled Post Market
PICATO02400995Cancelled Post Market
PONDOCILLIN PWS 175MG/5ML00582239Cancelled Post Market
PONDOCILLIN TAB 500MG00582247Cancelled Post Market
SELEXID TAB 185MG00657212Cancelled Post Market

Notices of Compliance

Newest first.

  • ANZUPGOSeptember 24, 2026 · NOC 38351 · Supplement to a New Drug Submission (SNDS)
  • INNOHEPSeptember 22, 2026 · NOC 38332 · Supplement to a New Drug Submission (SNDS)
  • DOVOBET GEL; DOVOBET OINTMENTAugust 21, 2026 · NOC 38159 · Supplement to a New Drug Submission (SNDS)
  • FUCIBETMay 29, 2026 · NOC 37649 · Supplement to a New Drug Submission (SNDS)
  • FUCIDIN CREAM 2%; FUCIDIN OINTMENT 2%May 7, 2026 · NOC 37502 · Supplement to a New Drug Submission (SNDS)
  • FUCIDIN HMay 5, 2026 · NOC 37482 · Supplement to a New Drug Submission (SNDS)
  • PROTOPICApril 27, 2026 · NOC 37406 · Supplement to a New Drug Submission (SNDS)
  • ENSTILARApril 21, 2026 · NOC 37373 · Supplement to a New Drug Submission (SNDS)
  • ADTRALZAMarch 26, 2026 · NOC 37195 · Supplement to a New Drug Submission (SNDS)
  • SPEVIGOMarch 26, 2026 · NOC 37202 · New Drug Submission (NDS)
  • FINACEAMarch 4, 2026 · NOC 37033 · Supplement to a New Drug Submission (SNDS)
  • ANZUPGOAugust 25, 2025 · NOC 35893 · New Drug Submission (NDS)
  • INNOHEPJune 24, 2025 · NOC 35584 · Supplement to a New Drug Submission (SNDS)
  • INNOHEPJune 13, 2025 · NOC 35523 · Supplement to a New Drug Submission (SNDS)
  • FINACEAMarch 14, 2025 · NOC 35013 · Supplement to a New Drug Submission (SNDS)
  • INNOHEPMarch 28, 2024 · NOC 32993 · Supplement to a New Drug Submission (SNDS)
  • INNOHEPNovember 17, 2023 · NOC 32139 · Supplement to a New Drug Submission (SNDS)
  • ADTRALZAAugust 4, 2023 · NOC 31382 · Supplement to a New Drug Submission (SNDS)
  • ADTRALZAJuly 12, 2023 · NOC 31195 · Supplement to a New Drug Submission (SNDS)
  • ADTRALZAFebruary 3, 2023 · NOC 30059 · Supplement to a New Drug Submission (SNDS)
  • ENSTILARMay 17, 2022 · NOC 28201 · Supplement to a New Drug Submission (SNDS)
  • ENSTILARApril 27, 2022 · NOC 28028 · Supplement to a New Drug Submission (SNDS)
  • DOVONEXDecember 16, 2021 · NOC 27261 · Supplement to a New Drug Submission (SNDS)
  • ENSTILAROctober 25, 2021 · NOC 26904 · Supplement to a New Drug Submission (SNDS)
  • ADTRALZAOctober 13, 2021 · NOC 26843 · New Drug Submission (NDS)
  • PROTOPICAugust 13, 2021 · NOC 26440 · Supplement to a New Drug Submission (SNDS)
  • FINACEAOctober 26, 2020 · NOC 24500 · Supplement to a New Drug Submission (SNDS)
  • FINACEASeptember 18, 2019 · NOC 22678 · New Drug Submission (NDS)
  • PROTOPICOctober 12, 2018 · NOC 21419 · Supplement to a New Drug Submission (SNDS)
  • FUCIBETApril 12, 2018 · NOC 20730 · New Drug Submission (NDS)
  • INNOHEPNovember 10, 2017 · NOC 20030 · Supplement to a New Drug Submission (SNDS)
  • ENSTILARSeptember 13, 2016 · NOC 18473 · New Drug Submission (NDS)
  • SELEXIDJuly 29, 2016 · NOC 18325 · Supplement to a New Drug Submission (SNDS)
  • PROTOPICJune 22, 2016 · NOC 18198 · New Drug Submission (NDS)
  • INNOHEPMarch 23, 2016 · NOC 17917 · Supplement to a New Drug Submission (SNDS)
  • DOVOBET GELOctober 23, 2015 · NOC 17418 · Supplement to a New Drug Submission (SNDS)
  • INNOHEPMay 27, 2015 · NOC 16934 · Supplement to a New Drug Submission (SNDS)
  • INNOHEPNovember 29, 2013 · NOC 14953 · Supplement to a New Drug Submission (SNDS)
  • DOVOBET GELFebruary 15, 2013 · NOC 14120 · Supplement to a New Drug Submission (SNDS)
  • PICATOJanuary 30, 2013 · NOC 14051 · New Drug Submission (NDS)
  • DOVOBET GELJuly 18, 2012 · NOC 13487 · Supplement to a New Drug Submission (SNDS)
  • INNOHEP (UNIT DOSE PRE FILLED SYRINGES); INNOHEP (UNIT DOSE PRE FILLED SAFETY SYRINGES)October 14, 2010 · NOC 11811 · Supplement to a New Drug Submission (SNDS)
  • XAMIOLNovember 6, 2008 · NOC 9871 · New Drug Submission (NDS)
  • DOVOBETNovember 6, 2008 · NOC 9874 · Supplement to a New Drug Submission (SNDS)
  • DOVONEXOctober 11, 2007 · NOC 9079 · Supplement to a New Drug Submission (SNDS)
  • CANAURAL (EAR DROPS)August 26, 2003 · NOC 3410 · New Drug Submission (NDS)
  • FUCITHALMIC VET (VISCOUS EYE DROPS)August 14, 2003 · NOC 3412 · New Drug Submission (NDS)
  • FUCIDERM GELAugust 14, 2003 · NOC 3414 · New Drug Submission (NDS)
  • DOVOBET OINTMENTMarch 20, 2002 · NOC 382 · Supplement to a New Drug Submission (SNDS)
  • DOVOBET OINTMENTJuly 11, 2001 · NOC 2121 · New Drug Submission (NDS)
  • FUCITHALMIC (WITH PRESERVATIVE); FUCITHALMIC (WITHOUT PRESERVATIVE)May 24, 2001 · NOC 2270 · New Drug Submission (NDS)
  • DOVONEXApril 4, 2000 · NOC 1059 · Supplement to a New Drug Submission (SNDS)
  • ONE-ALPHAJune 16, 1999 · NOC 1579 · Supplement to a New Drug Submission (SNDS)
  • ONE-ALPHAJanuary 14, 1999 · NOC 1596 · Supplement to a New Drug Submission (SNDS)
  • INNOHEPMay 24, 1995 · NOC 5274 · New Drug Submission (NDS)

Recalls and safety alerts that mention its products

Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.